Identifying pregnant women at risk for early attrition from substance abuse treatment

Journal of Substance Abuse Treatment
Wendy B KissinMaxine L Stitzer

Abstract

Greater treatment retention among pregnant substance abusers is associated with improved pregnancy and neonatal outcomes, so early identification of clients most at risk for early attrition is essential. Participants were 152 pregnant women enrolled in the initial 7-day residential component of a comprehensive substance abuse treatment program for pregnant women. Twenty-nine (19%) women left treatment within the first 5 days, primarily within the first 2 days. Clinical staff identified many, but not all, patients who eventually left treatment early as many indicated their desire to leave and were troubled by drug craving and withdrawal. Other predictors of attrition included not receiving methadone maintenance, being Caucasian, and reporting more prior drug treatment episodes, fewer medical problems and, to a lesser extent, more family/social and psychiatric and fewer drug problems on the Addiction Severity Index. Interventions are needed to target pregnant clients most at risk for early treatment attrition.

References

Jan 1, 1985·Journal of Substance Abuse Treatment·R J Craig
Feb 1, 1985·The International Journal of the Addictions·B S BrownP Thompson
Jul 1, 1985·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Jan 1, 1980·The Journal of Nervous and Mental Disease·A T McLellanC P O'Brien
Aug 1, 1995·American Journal of Public Health·P H HughesJ C Anthony
Aug 1, 1996·The American Journal of Drug and Alcohol Abuse·A C Roberts, R H Nishimoto
Aug 1, 1996·The American Journal of Drug and Alcohol Abuse·M P Laken, J W Ager
Jul 1, 1996·Journal of Substance Abuse Treatment·L M JanssonF Hackerman
Apr 14, 1997·Drug and Alcohol Dependence·D S SvikisC E Ball
Jul 1, 1997·Journal of Substance Abuse Treatment·K BellJ Anastas
May 4, 1999·Journal of Health Care for the Poor and Underserved·C E Grella
Nov 9, 2000·The Journal of Behavioral Health Services & Research·J Scott-LennoxR Lennox
May 3, 2001·Journal of Psychoactive Drugs·M DaleyC N Williams
Mar 6, 2002·The American Journal on Addictions·Lynne SiquelandLester Luborsky
Sep 19, 2003·American Journal of Perinatology·Bertis B LittleWalter L Johnston

❮ Previous
Next ❯

Citations

Jan 11, 2008·Primary Care Companion to the Journal of Clinical Psychiatry·Chaya G BhuvaneswarTheodore A Stern
Dec 17, 2008·Women's Health·Barry M Lester, Jean E Twomey
Jan 13, 2009·Substance Use & Misuse·Robert Walker
Jun 28, 2008·The American Journal of Drug and Alcohol Abuse·Mary M MitchellWilliam W Latimer
Apr 20, 2011·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Suzanne WongUNKNOWN Society of Obstetricians and Gynaecologists of Canada
Apr 7, 2011·Journal of Substance Abuse Treatment·Yih-Ing HserNena Messina
Mar 1, 2011·Journal of Substance Abuse Treatment·Jennifer AlbrechtMishka Terplan
Dec 14, 2007·Journal of Substance Abuse Treatment·John J McCarthyLagen A Biles
Feb 6, 2008·Journal of Substance Abuse Treatment·Hendree E JonesGabriele Fischer
Feb 13, 2013·The American Journal on Addictions·R Kathryn McHughMichael W Otto
Apr 11, 2014·Journal of Clinical Psychology·Karen Leggett DugoshDouglas B Marlowe
Oct 11, 2013·Substance Use & Misuse·Wayne H DentonTheresa Winhusen
Feb 23, 2012·The American Journal of Drug and Alcohol Abuse·Michelle TutenHendrée E Jones
Jun 1, 2009·Addictive Disorders & Their Treatment·Margaret S ChisolmHendrée E Jones
May 24, 2018·Substance Abuse Treatment, Prevention, and Policy·Ehsan JozaghiJane A Buxton
Aug 30, 2011·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Suzanne WongUNKNOWN Society of Obstetricians and Gynecologists of Canada
Oct 23, 2020·Substance Abuse : Research and Treatment·Fivos E Papamalis
Dec 31, 2021·Journal of Ethnicity in Substance Abuse·Asnina AnandanDarshan Singh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.